A double-blind, placebo-controlled, randomised trial to determine the ocular pharmacokinetics and safety of oral FT011 in patients with glaucoma.
Latest Information Update: 08 Jul 2020
At a glance
- Drugs FT 011 (Primary)
- Indications Glaucoma
- Focus Pharmacokinetics
- Sponsors OccuRx
- 07 Jul 2020 Status changed from recruiting to completed.
- 04 Jun 2019 Status changed from not yet recruiting to recruiting.
- 08 Jan 2019 Planned initiation date changed from 1 Feb 2018 to 31 Jan 2019.